MARKET

PAHC

PAHC

Phibro Animl
NASDAQ

Real-time Quotes | Nasdaq Last Sale

29.12
+0.42
+1.46%
After Hours: 29.12 0 0.00% 16:00 06/24 EDT
OPEN
28.91
PREV CLOSE
28.70
HIGH
29.15
LOW
28.62
VOLUME
48.14K
TURNOVER
--
52 WEEK HIGH
30.56
52 WEEK LOW
16.27
MARKET CAP
1.18B
P/E (TTM)
27.49
1D
5D
1M
3M
1Y
5Y
PAHC vs. ABT: Which Stock Should Value Investors Buy Now?
Zacks.com · 4h ago
Illumina's (ILMN) NovaSeq Adoption Aids, Margin Woe Stays
Illumina (ILMN) derives benefits from the cascading effect of the ACOG guidance on increasing coverage of NIPT for all pregnancies.
Zacks · 2d ago
Hologic (HOLX) to Beat Post-COVID Woes With Mobidiag Buyout
Hologic (HOLX) management believes that Mobidiag has created a differentiated platform that deals with many of the historical challenges faced in multiplexed point-of-care molecular testing.
Zacks · 2d ago
3 Discounted MedTech Stocks Poised for Sturdy Growth in 2021
Fundamentally-sound stocks like Henry Schein (HSIC), UnitedHealth Group (UNH) and Phibro Animal Health (PAHC) are trading at a discount and make great picks for the long term.
Zacks · 2d ago
Phirbo (PAHC) Nutritional Specialties Grow, Vaccine Sales Dip
Currently, Phirbo (PAHC) is focused on expanding its footprint in the poultry, swine and cattle industries, in both domestic and international markets.
Zacks · 06/15 14:59
Stocks That Hit 52-Week Highs On Wednesday
    During Wednesday's morning trading, 251 companies set new 52-week highs.
Benzinga · 06/09 14:05
Ex-Dividend Date Insight: Phibro Animal Health
On May 3, 2021, Phibro Animal Health (NASDAQ:PAHC) announced shareholders can expect to receive a dividend payable on June 23, 2021. The stock will then go ex-dividend 1 business day(s) before the record date.
Benzinga · 05/28 14:29
The Top Ten Competitors In The Veterinary Pharmaceuticals Industry Take Up Over 70% Of The Market
According to The Business Research Company's research report on the veterinary pharmaceuticals market, the animal pharmaceuticals market is concentrated with a small number of large players dominating the market. The top ten competitors in the market made ...
GlobeNewswire · 05/26 15:30
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of PAHC. Analyze the recent business situations of Phibro Animl through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 6 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average PAHC stock price target is 22.00 with a high estimate of 25.00 and a low estimate of 18.00.
EPS
Institutional Holdings
Institutions: 231
Institutional Holdings: 27.29M
% Owned: 67.37%
Shares Outstanding: 40.50M
TypeInstitutionsShares
Increased
53
2.26M
New
19
735.83K
Decreased
51
1.30M
Sold Out
14
967.27K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
+1.03%
Pharmaceuticals & Medical Research
+1.15%
Key Executives
Chairman/President/Chief Executive Officer/Director
Jack Bendheim
Chief Financial Officer
Damian Finio
Corporate Executive/Director
Jonathan Bendheim
Corporate Executive
Rob Aukerman
Chief Operating Officer
Larry Miller
Executive Vice President/Director
Daniel Bendheim
Senior Vice President/General Counsel/Secretary
Thomas Dagger
Senior Vice President/Director of Human Resources
Lisa Escudero
Vice President - Finance/Treasurer
Anthony Andolino
Independent Director
Gerald Carlson
Independent Director
E. Thomas Corcoran
Independent Director
Sam Gejdenson
Independent Director
Mary Malanoski
Independent Director
Carol Wrenn
Declaration Date
Dividend Per Share
Ex-Div Date
05/03/2021
Dividend USD 0.12
06/01/2021
02/01/2021
Dividend USD 0.12
03/02/2021
11/02/2020
Dividend USD 0.12
11/24/2020
07/27/2020
Dividend USD 0.12
09/01/2020
05/04/2020
Dividend USD 0.12
06/02/2020
02/03/2020
Dividend USD 0.12
03/03/2020
11/04/2019
Dividend USD 0.12
11/26/2019
07/29/2019
Dividend USD 0.12
09/03/2019
05/06/2019
Dividend USD 0.12
06/04/2019
02/06/2019
Dividend USD 0.12
03/05/2019
11/05/2018
Dividend USD 0.12
11/27/2018
07/30/2018
Dividend USD 0.1
09/04/2018
05/07/2018
Dividend USD 0.1
06/05/2018
02/05/2018
Dividend USD 0.1
03/06/2018
11/06/2017
Dividend USD 0.1
12/05/2017
07/24/2017
Dividend USD 0.1
09/01/2017
05/08/2017
Dividend USD 0.1
05/26/2017
02/06/2017
Dividend USD 0.1
02/27/2017
11/07/2016
Dividend USD 0.1
11/28/2016
07/25/2016
Dividend USD 0.1
09/02/2016
About PAHC
Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products. The Company also manufactures and markets specific ingredients for use in the personal care, automotive, industrial chemical and chemical catalyst industries. The Company's Medicated Feed Additives (MFAs) and other business consist of concentrated medicated products, which are administered through animal feeds. The Company's MFAs and other business consists of the production and sale of antibacterials, including Stafac, Terramycin, Neo-Terramycin and Mecadox and anticoccidials, including Nicarb, Aviax, Aviax Plus, Coxistac and amprolium.

Webull offers kinds of Phibro Animal Health Corp stock information, including NASDAQ:PAHC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PAHC stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PAHC stock methods without spending real money on the virtual paper trading platform.